Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-06

Clinical Trial Update: Midodrine During Recovery From Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating midodrine for recovery from septic shock has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)

Snippet

Sponsor: Northwell Health | Conditions: Hypotension, Shock, Septic | Phase 4 | Status: WITHDRAWN